The biotechnology industry has long been characterized by astronomical development costs and lengthy timelines that can stretch into decades. Traditional ...
There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will ...
Uncover the potential of repurposing medications to revolutionize the treatment landscape for orphan diseases and improve ...
Malaria is a lethal parasitic infectious disease caused by Plasmodium protozoa. Despite significant advancements in ...
Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...
A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It ...
Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...
Palantir is now working directly with Nvidia to fuse CUDA‑X accelerated computing and Nemotron open AI models into the core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback